Literature DB >> 11726910

One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.

A Koster1, O Meyer, T Fischer, M Kukucka, T Krabatsch, M Bauer, H Kuppe, R Hetzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11726910     DOI： 10.1067/mtc.2001.118271

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  8 in total

1.  Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies.

Authors:  Christian Schreiber; W Dietrich; S Braun; M Kostolny; A Eicken; R Lange
Journal:  Clin Res Cardiol       Date:  2006-06-20       Impact factor: 5.460

Review 2.  Thrombin inhibitors and cardiopulmonary bypass.

Authors:  Alan Merry
Journal:  J Extra Corpor Technol       Date:  2006-03

3.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Gowthami M Arepally; Beng H Chong; Douglas B Cines; Andreas Greinacher; Yves Gruel; Lori A Linkins; Stephen B Rodner; Sixten Selleng; Theodore E Warkentin; Ashleigh Wex; Reem A Mustafa; Rebecca L Morgan; Nancy Santesso
Journal:  Blood Adv       Date:  2018-11-27

Review 4.  [Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia].

Authors:  S A Kozek-Langenecker
Journal:  Anaesthesist       Date:  2008-06       Impact factor: 1.041

5.  Heparin-induced thrombocytopenia associated with massive intracardiac thrombosis: a case report.

Authors:  Atheer Ahmed; Hamid Al-Mondhiry; Truman J Milling; David Campbell
Journal:  Case Rep Hematol       Date:  2012-03-29

6.  A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates.

Authors:  Meimei Chen; Xiaohui Ye; Xin Ming; Yahui Chen; Ying Wang; Xingli Su; Wen Su; Yi Kong
Journal:  Sci Rep       Date:  2015-06-02       Impact factor: 4.379

Review 7.  Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.

Authors:  Matteo Marchetti; Maxime G Zermatten; Debora Bertaggia Calderara; Alessandro Aliotta; Lorenzo Alberio
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

8.  Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses.

Authors:  Rebecca L Morgan; Vahid Ashoorion; Adam Cuker; Housne Begum; Stephanie Ross; Nina Martinez; Beng H Chong; Lori A Linkins; Theodore E Warkentin; Wojtek Wiercioch; Robby Nieuwlaat; Holger Schünemann; Nancy Santesso
Journal:  Blood Adv       Date:  2020-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.